Clinical Trials Directory

Trials / Completed

CompletedNCT02323672

Salivary and Serum Levels of Chemerin and MMP-9 in Oral Premalignant and Malignant Lesions

Salivary and Serum Levels of Chemerin and MMP-9 in Oral Precancer and Oral Squamous Cell Carcinoma.

Status
Completed
Phase
Study type
Observational
Enrollment
45 (actual)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
40 Years – 50 Years
Healthy volunteers
Accepted

Summary

45 individuals were subdivided into 3 groups, 15 patients with oral premalignant lesions, 15 patients with oral malignant lesions and 15 control individuals. Levels of chemerin and MMP-9 were evaluated in serum and saliva of these subjects utilizing the ELISA technique.

Detailed description

45 individuals were subdivided into 3 groups, 15 patients suffering from oral premalignant lesions, 15 patients suffering from oral malignant lesions and 15 individuals having age, gender and periodontal status matched with both patients groups acting as a control group. Serum and whole unstimulated saliva samples were collected from all the included groups in order to determine chemerin and MMP-9 in serum and saliva utilizing the ELISA technique.

Conditions

Timeline

Start date
2014-02-01
Primary completion
2014-09-01
Completion
2014-10-01
First posted
2014-12-23
Last updated
2017-02-10

Source: ClinicalTrials.gov record NCT02323672. Inclusion in this directory is not an endorsement.

Salivary and Serum Levels of Chemerin and MMP-9 in Oral Premalignant and Malignant Lesions (NCT02323672) · Clinical Trials Directory